(R)-2-(tert-Butoxycarbonyl)-6-hydroxy-1,2,3,4-tetrahydroisoquinoline-1-carboxylic acid

Catalog No. :
ACRQEJ561
CAS No. :
2089671-79-2
Molecular Formula :
C15H19NO5
Molecular Weight :
293.32

IUPAC Name:(R)-2-(tert-butoxycarbonyl)-6-hydroxy-1,2,3,4-tetrahydroisoquinoline-1-carboxylic acid

(R)-2-(tert-Butoxycarbonyl)-6-hydroxy-1,2,3,4-tetrahydroisoquinoline-1-carboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg98%$1224.00Login to see priceInquiryInquiry
1g98%$1959.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(R)-2-(tert-Butoxycarbonyl)-6-hydroxy-1,2,3,4-tetrahydroisoquinoline-1-carboxylic acid
IUPAC Name(R)-2-(tert-butoxycarbonyl)-6-hydroxy-1,2,3,4-tetrahydroisoquinoline-1-carboxylic acid
MDL No.MFCD30829725
Molecular FormulaC15H19NO5
Molecular Weight293.32
SMILESO=C(O)[C@@H]1N(CCC2=C1C=CC(O)=C2)C(OC(C)(C)C)=O
InChI KeyKCDBTPOYUDNXBR-GFCCVEGCSA-N
Synonym(R)-2-(TERT-BUTOXYCARBONYL)-6-HYDROXY-1,2,3,4-TETRAHYDROISOQUINOLINE-1-CARBOXYLIC ACID;1,2(1H)-Isoquinolinedicarboxylic acid, 3,4-dihydro-6-hydroxy-, 2-(1,1-dimethylethyl) ester, (1R)-
CAS No.2089671-79-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACRQEJ561 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACNJOQ784 route compound structure diagram
    ACNJOQ7841389890-72-5 In Stock
  4. Then
  5. ACRQEJ561 route product structure diagram
    ACRQEJ5612089671-79-2
Inquiry

2. ACRQEJ561 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACRQEJ561 route product structure diagram
    ACRQEJ5612089671-79-2
Inquiry

Comments (0)